<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03903237</url>
  </required_header>
  <id_info>
    <org_study_id>2018-02270; sp19Mueller2</org_study_id>
    <nct_id>NCT03903237</nct_id>
  </id_info>
  <brief_title>Herpes Zoster: Risk Factors, Complications and Special Situations</brief_title>
  <official_title>Herpes Zoster: Risk Factors, Complications and Special Situations- a Retrospective Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This retrospective analysis is to investigate patients` history and clinical presentation in
      Herpes Zoster (HZ), Zoster-related complications, post-Zoster neuralgia and Herpes Zoster
      management in order to improve the management of HZ patients, to refine HZ-vaccination
      strategies and elucidate cost factors of HZ in in the setting of a university hospital in
      Switzerland generally and in a dermatology department specifically.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 20, 2018</start_date>
  <completion_date type="Actual">February 28, 2019</completion_date>
  <primary_completion_date type="Actual">February 28, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of patients` history</measure>
    <time_frame>single time point assessment at baseline</time_frame>
    <description>Free text evaluation of patients` history (age, sex, comorbidities, immunosuppression, obesity, human immune deficiency Virus (HIV), profession, current medication, vaccinations, seasonal occurence of HZ, history of Varicella Zoster virus (VZV) infection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Description of the clinical presentation of HZ</measure>
    <time_frame>single time point assessment at baseline</time_frame>
    <description>Free text description of the clinical presentation of HZ (localisation, dermatomes affected), Zoster-related acute pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of zoster-related complications</measure>
    <time_frame>single time point assessment at baseline</time_frame>
    <description>Free text evaluation of zoster-related complications (ophthalmic zoster, generalised HZ, Ramsay-Hunt syndrome, zoster meningoencephalitis)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the herpes zoster management</measure>
    <time_frame>single time point assessment at baseline</time_frame>
    <description>Free text evaluation of the herpes zoster management (local (antiviral) treatment, systemic antiviral and other treatments, number of revisits, average treatment-related costs, hospitalisations (rate, duration)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of post-zoster neuralgia</measure>
    <time_frame>single time point assessment at baseline</time_frame>
    <description>Free text assessment of post-zoster neuralgia (annual incidence, treatment options used)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of zoster and pregnancy</measure>
    <time_frame>single time point assessment at baseline</time_frame>
    <description>Free text evaluation of zoster and pregnancy (incidence, time of pregnancy, pregnancy outcomes and complications)</description>
  </primary_outcome>
  <enrollment type="Actual">355</enrollment>
  <condition>Herpes Zoster</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>retrospective chart review</intervention_name>
    <description>retrospective report review of HZ patients treated between 2005 and 2018 in the Department of Dermatology at the University Hospital Basel</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with HZ who were seen at University Hospital Basel between 2004-2018
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Reports of patients with HZ at University Hospital Basel between 2004-2018

        Exclusion Criteria:

          -  rejection to use patient data
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Simon MÃ¼ller, Dr. med</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Dermatology, University Hospital Basel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Dermatology, University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 2, 2019</study_first_submitted>
  <study_first_submitted_qc>April 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2019</study_first_posted>
  <last_update_submitted>April 3, 2019</last_update_submitted>
  <last_update_submitted_qc>April 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>post-zoster neuralgia</keyword>
  <keyword>Herpes Zoster-related complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Herpes Zoster</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

